CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
Kai-Chun Wu, Zhi Hua Ran, Xiang Gao, Minhu Chen, Jie Zhong, Jian-Qiu Sheng, Michael A Kamm, Simon Travis, Kori Wallace, Nael M Mostafa, Marisa Shapiro, Yao Li, Roopal B Thakkar, Anne M Robinson
Intest Res. 2016;14(2):152-163.   Published online April 27, 2016
DOI: https://doi.org/10.5217/ir.2016.14.2.152

Excel Download

Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
Intestinal Research. 2016;14(2):152   Crossref logo
Link1

Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn's Disease: The CHARM Trial
Yearbook of Gastroenterology. 2007;2007:120   Crossref logo
Link1 Link2

INDUCTION AND MAINTENANCE OF CLINICAL RESPONSE AND REMISSION WITH CERTOLIZUMAB PEGOL IN PATIENTS WITH INFLAMMATORY OR FISTULISING CROHN'S DISEASE: A REFERRAL CENTER EXPERIENCE OF COMPASSIONATE USE
Digestive and Liver Disease. 2009;41:S126   Crossref logo
Link1 Link2

Exam 2: Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped
Gastroenterology. 2012;142(1):e31   Crossref logo
Link1 Link2

Su2084 Efficacy of Certolizumab Pegol Induction and Maintenance Therapy in Patients With Crohn's Disease Not in Remission Following Active or Placebo Induction
Gastroenterology. 2012;142(5):S-565   Crossref logo
Link1 Link2

Su1126 In Patients With Crohn's Disease, Concomitant Enteral Nutrition Reduces the Loss of Response to Adalimumab Maintenance Therapy
Gastroenterology. 2014;146(5):S-382   Crossref logo
Link1 Link2

Sa1968 Post-Induction Adalimumab Drug Levels Predict Clinical and Laboratory Remission at Week 24 in Patients With Crohn's Disease
Gastroenterology. 2016;150(4):S419   Crossref logo
Link1 Link2

Su1127 In Patients With Crohn's Disease, Timing of Switching From Infliximab Maintenance Therapy to Adalimumab Affects Patients' Prognosis
Gastroenterology. 2014;146(5):S-382   Crossref logo
Link1 Link2

Adalimumab maintenance therapy improves quality of life in patients with Crohn's disease
Nature Reviews Gastroenterology & Hepatology. 2009;6(3):129-129   Crossref logo
Link1 Link2 Link3

T1012 Long-Term Maintenance of Clinical Remission With Reduced Dosing Frequency of Adalimumab in Patients With Moderate to Severe Crohn's Disease
Gastroenterology. 2010;138(5):S-468-S-469   Crossref logo
Link1 Link2